3 ms·
Can you check your link? I think those are serology studies which cannot give an indication of efficacy. I believe you that recovered+vaccine gives stronger m
by peteradio 5y ago
Can you check your link? I think those are serology studies which cannot give an indication of efficacy. I believe you that recovered+vaccine gives stronger measurable antibodies but above some threshold more antibodies does not really give any indication of the two most important factors:
1) transmissibility
2) patient outcomes
What do you find when we compare recovered vs vaccine for those factors?
- tomrod 5y agoReinfection rates are pretty low, partially due to immunity, partially due to behavior (if you've had it you probably know you have it again), and partially because of data drift (federated data sources don't cleanly connect despite reporting to CDC). Vaccination breakthrough rates at point of testing are something like 1/20 to 1/100 versus the canonical susceptible population, without stratifying for ages or patient outcomes or correcting for population biases.
- peteradio 5y agoThank you for the information and conversation.
- tomrod 5y agoA tangent: the UK has some of the best monitoring implemented and sees antibodies in about 95% of its population. That said, reinfection rate as of June 2021 (roughly pre-Delta) was 0.4% over that population cohort. https://www.gov.uk/government/news/new-national-surveillance-of-possible-covid-19-reinfection-published-by-phe https://www.gov.uk/government/news/new-national-surveillance...